Boothbay Fund Management’s Zura Bio Limited Warrants ZURAW Stock Holding History

Boothbay Fund Management’s Portfolio ZURAW Stock Details ZURAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-52,926	Closed	-$185K	–	2032
2024 Q2	$185K	Buy	+52,926	New	+$26.8K	﹤0.01%	1301
2024 Q1	–	Sell	-12,650	Closed	-$59.1K	–	2005
2023 Q4	$59.1K	Sell	12,650 -1,579	-11%	-$682	﹤0.01%	1513
2023 Q3	$93.9K	Hold	14,229	–	–	﹤0.01%	1576
2023 Q2	$117K	Sell	14,229 -42,630	-75%	-$15K	﹤0.01%	1591
2023 Q1	$848K	Sell	56,859 -7,140	-11%	-$2.04K	0.02%	1064
2022 Q4	$653K	Buy	+63,999	New	+$6.26K	0.02%	1065

Boothbay Fund Management's ZURAW Position: Q3 2024 in Review

Boothbay Fund Management sold out of Zura Bio Limited Warrants (ZURAW) in Q3 2024, closing a stake of 52,926 shares — an estimated $185K sold.

Boothbay Fund Management first reported a position in ZURAW in Q4 2022 and held it in 6 quarters. The position peaked at $848K in Q1 2023. 0 funds tracked by Wall St. Rank hold ZURAW as of Q3 2024.

Boothbay Fund Management reported no remaining Zura Bio Limited Warrants position as of Q3 2024 after selling out during the quarter.
Boothbay Fund Management sold 52,926 Zura Bio Limited Warrants shares in Q3 2024, an estimated $185K.
Boothbay Fund Management first reported a position in Zura Bio Limited Warrants in Q4 2022 and held it in 6 quarters.
Boothbay Fund Management's Zura Bio Limited Warrants position peaked at $848K in Q1 2023.
0 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q3 2024.

Based on Boothbay Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.